|Bid||0.00 x 100|
|Ask||0.00 x 200|
|Day's Range||283.48 - 288.94|
|52 Week Range||215.52 - 290.84|
|Beta (3Y Monthly)||1.08|
|PE Ratio (TTM)||16.59|
|Earnings Date||Jan 30, 2019|
|Forward Dividend & Yield||3.00 (1.05%)|
|1y Target Est||319.32|
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Anthem (ANTM) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
NEW YORK, Nov. 14, 2018 -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Anthem, Inc. (NYSE: ANTM). On July 24,.
Given this chart and analysis, my trading strategy is to buy Aetna shares on weakness to annual value level of $161.49 and reduce holdings on strength to my quarterly risky level at $218.10. Given this chart and analysis, traders should buy Anthem shares on weakness to my annual value level of $194.00 and reduce holdings on strength to my quarterly risky level at $300.91. Given this chart and analysis, I suggest buying Humana shares on weakness to my annual value level of $253.11 and reducing holdings on strength to my quarterly risky level at $353.33, which was tested after the election on Nov. 7.
Humana earnings, the Democratic House takeover and Medicaid expansions in 3 states sent health insurers soaring Wednesday. Humana and several peers hit buy points.
Anthem (ANTM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Anthem, Inc. (ANTM) announced today that senior management is scheduled to present at the Credit Suisse 27th Annual Healthcare Conference on November 14, 2018, at 12:20 p.m. Eastern Standard Time (EST). Anthem is working to transform health care with trusted and caring solutions.
SAN DIEGO, CA / ACCESSWIRE / November 6, 2018 / The Shareholders Foundation, Inc. announces that a lawsuit was filed by a current investor in shares of Anthem, Inc. (NYSE: ANTM) over alleged breaches of ...
The company also reported higher-than-expected third quarter profit as it reined in costs. "We're entering 2019 in a position of strength," Chief Executive Officer Gail Boudreaux said on a conference call with analysts. Current 2019 consensus estimates for core earnings are "slightly below" Anthem's long-term high-single to low-double digit growth target, she added.
Inc.’s earnings climbed in the third quarter and the health insurer boosted its earnings guidance for the year. Analysts polled by Refinitiv were expecting earnings of $3.50 a share. Analysts polled by Refinitiv were expecting $22.94 billion.
Dividends can be underrated but they form a large part of investment returns, playing an important role in compounding returns in the long run. Historically, Anthem Inc (NYSE:ANTM) has been Read More...
Investing.com - Anthem (NYSE:ANTM) reported third quarter earnings that beat analyst's expectations on Wednesday and revenue that topped forecasts.
Anthem (ANTM) delivered earnings and revenue surprises of 3.81% and 0.32%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?